Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children

scientific article published on May 2014

Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/INF.0000000000000143
P932PMC publication ID3990384
P698PubMed publication ID24736440

P50authorPeter MugyenyiQ16732954
Mutsa Bwakura-DangarembiziQ57875617
Diana M GibbQ62738885
Lindsay KendallQ63630847
Ann Sarah WalkerQ90248231
Philippa MusokeQ96163738
ARROW Trial TeamQ114437759
Quirine FillekesQ114437776
P2093author name stringDavid Burger
Milly Ndigendawani
Sabrina Kitaka
P2860cites workRoutine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trialQ30539434
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenQ35947409
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.Q38868724
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW TrialQ38871183
A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adultsQ43580186
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hoursQ43673455
Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and childrenQ44343579
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.Q45843620
Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometryQ73904216
Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected childrenQ80988077
P433issue5
P921main subjectUgandaQ1036
World Health OrganizationQ7817
zidovudineQ198504
pharmacokineticsQ323936
P304page(s)495-498
P577publication date2014-05-01
P1433published inPediatric Infectious Disease JournalQ15756717
P1476titlePharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children
P478volume33